Searched for
ERTAPENEM
FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...- For US-facing pharma cos, Q2 & Q3 likely to be soft quarters: Nithya Balasubramanian“For the next couple of quarters, on a YoY basis, I am expecting that generic price deflation could be higher in the second as well as the ...
- Dr Reddy's launches generic Invanz injection in US marketWe're excited to extend our strategic partnership with Gland Pharma whose hard work, in collaboration with the team at Dr Reddys, has enabl...
- Buy Aurobindo Pharma, target price Rs 527: Nirmal BangWith China resuming supplies of raw materials, potential disruption in manufacturing is now no longer a concern.
- Buy Aurobindo Pharma, target Rs 836: Elara CapitalBuy Aurobindo Pharma Ltd. at a price target of Rs 836.
- Aurobindo Pharma rises 2% on USFDA nodEBITDA margin was below expectation, the brokerage said in its June 4 report.
- Bottom fishing, anyone? As market tanks, these are the stocks you can grabExperts say the second half of this calendar may not be as good for D-Street as was the first half.
- Government to ban over-the-counter sale of 92 antibioticsOver-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs will be clamped down in India soon.
- Superbug threat: Govt mulls introducing new 'schedule' in ActThe threat of a multi-drug resistant superbug looming large has forced the government to consider introduction of a separate schedule in th...
- New drug policy to curb misuse of antibioticsA formal proposal to create India’s first ever antibiotic policy will be submitted to the Union health ministry soon.
Load More
